Skip to content
OpenCapital
Get started

GeneDx Holdings WGS Institutional customers — Total Revenue

Similar metrics at other companies

Cohen & Steers logo
CNSInstitutional accounts — Total Revenue
$34.54M+7.4%
Amneal Pharmaceuticals, Inc. logo
AMRXInstitutional — Net revenue
$9.82M-10.8%
StoneX Group Inc. logo
SNEXInstitutional — Total revenues
$868.4M+54.7%
SEI Investments logo
SEICInstitutional Investors — Total Revenue
$71.52M+4.4%
Jackson Financial logo
JXNInstitutional Products — Total revenues
$143M+23.3%
Corebridge Financial logo
CRBGInstitutional Markets — Total Revenue
$760M-33.3%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.89B-24.3%
Enterprise value$1.89B-22.8%
P/S4.3×-3.3×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%—
Net margin-17.6%—
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%—
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's institutional customers — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's institutional customers — total revenue?
GeneDx Holdings (WGS) reported institutional customers — total revenue of $16.09M in Q1 2026.
How has GeneDx Holdings's institutional customers — total revenue changed year-over-year?
GeneDx Holdings's institutional customers — total revenue decreased by 8.6% year-over-year, from $17.6M to $16.09M.
What is the long-term trend for GeneDx Holdings's institutional customers — total revenue?
Over 4 years (2021 to 2025), GeneDx Holdings's institutional customers — total revenue has grown at a 21.8% compound annual growth rate (CAGR), from $31.72M to $69.8M.
What does institutional customers — total revenue mean?
This metric represents the total gross revenue generated from diagnostic testing services provided to institutional clients, such as hospitals, health systems, and research organizations. It serves as a key indicator of the company's market penetration and demand within the professional healthcare provider segment. Growth in this revenue stream reflects the successful adoption of diagnostic solutions by large-scale clinical partners.